Insider Holders & Insider Ownership - Zyla Life Sciences (ZCOR)

List of insiders holdings for Zyla Life Sciences:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 Atlas Venture Fund VII L P
10% Owner
2018-02-09 17:41:14 2,583,203
0
2,583,203 Form 13G
2 Danish Biotech SPV I P/S
Omega Fund IV L.P.
10% Owner
2017-02-14 11:18:03 2,575,352
0
2,575,352 Form 13G
3 FORMELA JEAN FRANCOIS
Director
10% Owner
2014-02-12 15:01:22 0
2,460,949
2,460,949 Form 4
4 SEGERROS ANDREAS Rutger
Director
10% Owner
2014-02-12 17:42:59 0
2,014,553
2,014,553 Form 4
5 SUNSTONE LIFE SCIENCE VENTURES FUND II K/S
10% Owner
2014-02-24 15:20:46 1,859,615
0
1,859,615 Form 13G
6 Index Venture Associates III Ltd
Index Ventures III (Jersey) L.P.
Index Ventures III (Delaware) L.P.
Index Ventures III Parallel Entrepreneur Fund (Jersey) L.P.
Yucca (Jersey) SLP
INDEX VENTURES LIFE VI (JERSEY) L.P.
10% Owner
2018-02-14 14:37:31 1,386,602
0
1,386,602 Form 13G
7 Riva Ridge Capital Management LP
RIVA RIDGE GP LLC
Golden Stephen H
Shim James
10% Owner
2020-02-12 17:15:20 938,661
0
938,661 Form 13G
8 Musial Stan
Chief Financial Officer
2018-06-15 17:31:37 347,407
0
347,407 Form 4
9 AGUIAR-LUCANDER RENEE
Director
2014-02-12 18:11:13 0
314,574
314,574 Form 4
10 Wilkins H Jeffrey
SVP and Chief Medical Officer
2019-07-01 21:13:55 190,000
0
190,000 Form 4
11 Shea Patrick M
Chief Commercial Officer
2019-03-28 16:01:21 90,000
0
90,000 Form 4
12 Dayno Jeffrey M.
Chief Medical Officer
2017-06-12 16:40:43 80,000
0
80,000 Form 4
13 Radie Robert S
Principal Financial Officer
2020-01-02 19:43:49 76,915
0
76,915 Form 4
14 LINDHARDT KARSTEN
VP, Research & Development
2016-07-06 17:57:48 40,000
0
40,000 Form 4
15 Melloy Deanne F.
Chief Commercial Officer
2016-04-06 16:03:05 33,420
0
33,420 Form 4
16 VARKI PAUL
SVP, GC & Chief Compliance Off
2017-07-06 16:47:14 29,514
0
29,514 Form 4
17 KOZLOV ANDREY
Director
2014-02-05 15:49:43 0
0
0 Form 3
18 McInnis Joe
Director
2020-05-21 16:33:31 0
0
0 Form 4
19 Strobeck Mark
Chief Operating Officer
2020-05-21 16:33:01 0
0
0 Form 4
20 Walbert Timothy P
Director
2020-05-21 16:32:30 0
0
0 Form 4
21 Smiley Andrea Heslin
Director
2020-05-21 16:32:15 0
0
0 Form 4
22 Phillips Gary M.
Director
2020-05-21 16:31:45 0
0
0 Form 4
23 Pauls Matthew
Director
2020-05-21 16:31:30 0
0
0 Form 4
24 SMITH TODD N
President and CEO
2020-05-21 16:31:15 0
0
0 Form 4
25 TIMMINS MEGAN C.
General Counsel
2020-05-21 16:30:46 0
0
0 Form 4
26 CR Group L.P.
CRG Partners III - Parallel Fund B (Cayman) L.P.
CRG Partners III - Parallel Fund (A) L.P.
CRG Partners III (Cayman) Lev AIV I L.P.
CRG Partners III (Cayman) Unlev AIV I L.P.
CRG Partners III L.P.
Loan Security Holdings I LLC
10% Owner
2020-05-22 16:07:17 0
0
0 Form 4
27 Capital Royalty L.P.
Iroko Pharmaceuticals Inc.
Iroko Properties Inc.
CRG Partners III (Cayman) Lev AIV I L.P.
CRG Partners III (Cayman) Unlev AIV I L.P.
CRG Partners III L.P.
Loan Security Holdings I LLC
CRG Partners III - Parallel Fund B (Cayman) L.P.
CRG Partners III - Parallel Fund (A) L.P.
10% Owner
2020-05-22 16:07:08 0
0
0 Form 13D
28 Duster Luke
Director
2019-06-24 18:11:43 0
0
0 Form 4
29 Holmes Todd
Director
2019-02-11 17:36:17 0
0
0 Form 3
30 ROCHE ROBERT P JR
Director
2019-02-04 20:12:10 0
0
0 Form 4
31 NICOLAIDES NICHOLAS C
Director
2019-02-04 20:11:56 0
0
0 Form 4
32 WEAVER GREGORY L
Director
2019-02-04 20:10:42 0
0
0 Form 4
33 OSBORN JOHN E
Director
2019-02-04 20:10:27 0
0
0 Form 4
34 Hochberg Elaine
Director
2019-02-04 20:10:10 0
0
0 Form 4
35 Varian John
Director
2019-02-04 20:09:19 0
0
0 Form 4
36 CARLIN BARBARA
Chief Accounting Officer
2019-02-04 18:32:35 0
0
0 Form 4